Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Aug 23;15(8):e43969.
doi: 10.7759/cureus.43969. eCollection 2023 Aug.

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

Affiliations
Case Reports

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

Josef Finsterer et al. Cureus. .

Abstract

Progressive mitochondrial encephalopathy manifesting as developmental delay, regression, epilepsy, myoclonus, dystonia, and spasticity due to a novel compound heterozygous variant in NARS2 has not been reported. The patient is a 3.5-year-old female with normal psychomotor development until she experienced her first generalized status epilepticus at 4.5 months of age. After seizure control, generalized myoclonus and psychomotor regression became evident. She suffered from two other epileptic states and seizure control remained inadequate despite the use of multiple anti-seizure drugs. Neurologic examination revealed generalized hypotonia, discoordination, unstable eye contact, drooling, open mouth, myoclonus, periodic torticollis, and ankle contractions. Cerebral MRI revealed hydrocephalus ex vacuo due to diffuse cortical and subcortical atrophy bilaterally and incomplete myelination. Genetic testing at 12 months of age revealed the compound heterozygous variants chr11: 78204182C>T and chr11: 78282446A>AG in NARS2. Despite anti-seizure drugs, mitochondrial cocktail, and cannabidiol, the disease progressed to intractable seizures and severe tetraspasticity. In summary, this case demonstrates that compound heterozygous variants in NARS2 can phenotypically manifest exclusively in the brain with intractable epilepsy, myoclonus, developmental delay, regression, hypotonia, cerebral atrophy, and hypomyelination, followed by tetraspasticity and dystonia.

Keywords: epilepsy; mitochondrial; mitochondrial encephalopathy; myoclonus; nars2; respiratory chain; spasticity.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Cerebral MRI, T2-weighted images, at age 27 months showing hydrocephalus with dilation of lateral ventricles (B) due to reduced volume of the cortex (A), white matter, slight asymmetry of hippocampi (R > L), hyperintensities of the temporal poles bilaterally (C, D) and anterior parts of frontal lobes, smoothing of the cortico-medullary differentiation as a manifestation of incomplete myelination
Figure 2
Figure 2. Cerebral MRI, fluid-attenuated inversion recovery (FLAIR) images, at age 27 months, showing hypomyelination supratentorially (A-C) and infratentorially (D-F), with right-sided predominance

Similar articles

Cited by

References

    1. A new entity in the NARS2 variant: the first reported case of type 1 diabetes mellitus associated with the phenotype. Cokyaman T, Cetin H, Dogan D, Silan F. J Trop Pediatr. 2022;69:0. - PubMed
    1. Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS. Bonnefond L, Fender A, Rudinger-Thirion J, Giegé R, Florentz C, Sissler M. Biochemistry. 2005;44:4805–4816. - PubMed
    1. Clinical and genetic analyses of premature mitochondrial encephalopathy with epilepsia partialis continua caused by novel biallelic NARS2 mutations. Hu W, Fang H, Peng Y, et al. Front Neurosci. 2022;16:1076183. - PMC - PubMed
    1. Splicing variants in NARS2 are associated with milder phenotypes and intra-familial variability. Ait-El-Mkadem Saadi S, Kaphan E, Morales Jaurrieta A, et al. Eur J Med Genet. 2022;65:104643. - PubMed
    1. Bilateral nonsyndromic sensorineural hearing loss caused by a NARS2 mutation. Al-Sharif F, Alsadeq H, Rozan A, et al. Cureus. 2022;14:0. - PMC - PubMed

Publication types

LinkOut - more resources